Loading
Life sciences · Journal article
Health Care of Tajikistan · October 8, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Obesity and type 2 diabetes mellitus (T2DM) are among the most significant components of metabolic syndrome, exerting a critical impact on the morbidity, disability and mortality of the population. In recent years, bariatric interventions have come to be regarded not only as methods of weight loss, but also as effective means of achieving remission of T2DM. Various surgical techniques, such as sleeve gastrectomy, gastric bypass, and biliopancreatic diversion, have demonstrated high rates of glycated hemoglobin reduction, decreased need for hypoglycemic drugs, and stable diabetes remission. This article summarizes data from clinical studies, randomized controlled trials, and systematic reviews published in leading international databases in recent years, allowing for an evaluation of the efficacy and safety of bariatric surgery in patients with obesity and T2DM. Particular attention is paid to the factors influencing the treatment prognosis, as well as to current concepts regarding the mechanisms underlying the metabolic effects of surgical interventions.